430
Views
36
CrossRef citations to date
0
Altmetric
Original Articles

Transepithelial Transport Characteristics of the Antihypertensive Peptide, Lys-Val-Leu-Pro-Val-Pro, in Human Intestinal Caco-2 Cell Monolayers

, , &
Pages 293-298 | Received 08 Jul 2008, Accepted 24 Oct 2008, Published online: 22 May 2014

  • 1) Imazu, M., Hypertension and insulin disorders. Curr. Hypertens. Rep., 4, 477–482 (2002).
  • 2) Karaki, H., Doi, K., and Sugano, S., Antihypertensive effect of tryptic hydrolyzate of milk casein in spontaneously hypertensive rats. Comp. Biochem. Physiol., 96, 367–371 (1990).
  • 3) Yoshikawa, M., Fujita, H., and Matoba, N., Bioactive peptides derived from food proteins preventing lifestyle-related diseases. Biofactors, 12, 143–146 (2000).
  • 4) Fujita, H., Yokoyama, K., and Yoshikawa, M., Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J. Food Sci., 65, 564–569 (2000).
  • 5) Arai, S., Osawa, T., and Ohigashi, H., A mainstay of functional food science in Japan: history, present status, and future outlook. Biosci. Biotechnol. Biochem., 65, 1–13 (2001).
  • 6) Pappenheimer, J. R., Dahl, C. E., and Karnovsky, M. L., Intestinal absorption and excretion of octapeptides composed of D-amino acids. Proc. Natl. Acad. Sci. USA, 91, 1942–1945 (1994).
  • 7) Adson, A., Raub, T. J., and Burton, P. S., Quantitative approaches to declineate paracellular diffusion in cultured epithelial cell monolayers. J. Pharm. Sci., 83, 1529–1536 (1994).
  • 8) Shimizu, M., Tsunogai, M., and Arai, S., Transepithelial transport of oligopeptides in the human intestinal cell, Caco-2. Peptides, 18, 681–687 (1997).
  • 9) Sai, M., Kajita, M., and Tamai, I., Adsorptive-mediated endocytosis of a basic peptide in erythrocyte-like Caco-2 cells. Am. J. Physiol., 275, 514–520 (1998).
  • 10) Fei, Y. J., Kanai, Y., and Nussberger, S., Expression cloning of a mammalian proton-coupled oligopeptides transporter. Nature, 368, 563–566 (1994).
  • 11) Liang, R., Fei, Y. J., and Prasad, P. D., Human intestinal H+/peptide cotransporter. J. Biol. Chem., 270, 6456–6463 (1995).
  • 12) Liu, D., Sun, H. Y., and Zhang, L. J., High-level expression of milk-derived AHP in Escherichia coli and its bioactivity. J. Agric. Food Chem., 55, 5109–5112 (2007).
  • 13) Hidalgo, I. J., Raub, T. J., and Borchardt, R. T., Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96, 736–749 (1989).
  • 14) Artursson, P., Palm, K., and Luthman, K., Caco-2 monolayers in experimental and theoretical predictions of drug transport. Drug Deliv. Rev., 46, 27–43 (2001).
  • 15) Zhu, X. L., Matsui, T., Watanabe, K., Shiraishi, K., Ueki, T., and Matsumoto, K., Simultaneous determination of Angiotensin I-converting enzyme inhibitory peptides in tryptic casein hydrolysate by high-performance liquid chromatography combined with a replicate heart-cut column-switching technique. J. Agric. Food Chem., 55, 8367–8371 (2007).
  • 16) Irvine, J. D., Takahashi, L., and Lockhart, K., MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening. J. Pharm. Sci., 88, 28–33 (1999).
  • 17) Augustijns, P. F., Bradshaw, T. P., and Gan, L. S., Evidence for a polarized efflux system in Caco-2 cells capable of modulating cyclosporin A transport. Biochem. Biophys. Res. Commun., 197, 360–365 (1993).
  • 18) Li, H., Chung, S. J., and Kim, D. C., The transport of a reversible proton pump antagonist, 5,6-dimethyl-2-(4-fluorophenylamino)-4-(1-methyl-1,2,3,4-tetrahydroisoquinoline-2-yl) pyrimidine hydrochloride (YH1885), across Caco-2 cell monolayers. Drug Metab. Dispos., 29, 54–59 (2001).
  • 19) Matsumoto, S.-I., Saito, H., and Inui, K.-I., Transcellular transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: interaction with dipeptide transport systems in apical and basolateral membranes. J. Pharmacol. Exp. Ther., 270, 498–504 (1994).
  • 20) Gan, L. S., Hsyu, P. H., Pritchard, J. F., and Thakker, D. R., Mechanism of intestinal absorption of ranitidine and ondansetron: transport across Caco-2 cell monolayers. Pharm. Res., 10, 1722–1725 (1993).
  • 21) Karnes, H. T., Shiu, G., and Shah, V. P., Validation of bioanalytical methods. Pharm. Res., 8, 421–426 (1991).
  • 22) Tsuji, A., and Tamai, I., Carrier-mediated intestinal transport of drugs. Pharmcol. Res., 13, 963–977 (1996).
  • 23) Artursson, P., and Karlsson, J., Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun., 175, 880–885 (1991).
  • 24) Liao, K., Hoffman, R. D., and Lane, M. D., Phosphotyrosyl turnover in insulin signaling: characterization of two membrane-bound pp15 protein tyrosine phosphatases from 3T3-L1 adipocytes. J. Biol. Chem., 266, 6544–6553 (1991).
  • 25) Lo, Y. L., and Huang, J. D., Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. Biochem. Pharmacol., 59, 665–672 (2000).
  • 26) Richard, A., Walgren, U., Kristina, W., and Thomas, W., Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol., 55, 1721–1727 (1998).
  • 27) Dyer, J., Beechey, R. B., and Gorvel, J. P., Glycyl-L-Proline transport in rabbit enterocyte basolateral-membrane vesicles. Biochem. J., 269, 565–571 (1990).
  • 28) Saito, H., and Inui, K., Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am. J. Physiol., 265, 289–294 (1993).
  • 29) Enjoh, M., Hashimoto, K., and Arai, S., Inhibitory effect of arphamenine A on intestinal dipeptide transport. Biosci. Biotechnol. Biochem., 60, 1893–1895 (1996).
  • 30) Hashimoto, K., and Shimizu, M., Epithelial properties of human intestinal Caco-2 cells cultured in serum-free medium. Cytotechnology, 13, 175–184 (1993).
  • 31) Satake, M., Enjoh, M., Nakamura, Y., Takano, T., Kawamura, Y., Arai, S., and Shimizu, M., Transepithelial transport of bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci. Biotechnol. Biochem., 66, 378–384 (2002).
  • 32) Vermeirssen, V., Deplancke, B., Tappenden, K. A., Vancamp, J., Gaskins, H. R., and Verstraete, W., Intestinal transport of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg through a Caco-2 bbe monolayer. J. Pept. Sci., 8, 95–100 (2002).
  • 33) Quirós, A., Dóvalosb, A., Lasunción, M. A., Ramos, M., and Recio, I., Bioavailability of the antihypertensive peptide LHLPLP: transepithelial flux of HLPLP. Int. Dairy J., 18, 279–286 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.